Avidity Biosciences, Inc. (RNA)

NASDAQ: RNA · IEX Real-Time Price · USD

38.80

-2.48 (-6.01%)

At close: Jul 2, 2024, 4:00 PM

38.51

-0.29 (-0.75%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Avidity Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-212.22	-174	-118.01	-44.36	-24.73	Upgrade
Depreciation & Amortization	5.08	4.14	1.33	0.37	0.35	Upgrade
Share-Based Compensation	38.22	27.14	17.06	4.31	0.41	Upgrade
Other Operating Activities	49.86	6.45	4.81	2.56	26.47	Upgrade
Operating Cash Flow	-119.06	-136.27	-94.81	-37.12	2.49	Upgrade
Capital Expenditures	-4.23	-2.82	-3.74	-1.09	-0.24	Upgrade
Change in Investments	-125.84	-187.13	-78.78	-6.69	0	Upgrade
Investing Cash Flow	-130.07	-189.96	-82.52	-7.79	-0.24	Upgrade
Dividends Paid	0	0	0	0	-0.11	Upgrade
Share Issuance / Repurchase	93.86	346.17	176.32	274.52	0.07	Upgrade
Debt Issued / Paid	0	0	0	-4.68	16.65	Upgrade
Other Financing Activities	-	-	-	2.2	72.62	Upgrade
Financing Cash Flow	93.86	346.17	176.32	272.04	89.23	Upgrade
Net Cash Flow	-155.27	19.95	-1.01	227.14	91.49	Upgrade
Free Cash Flow	-123.29	-139.09	-98.55	-38.21	2.26	Upgrade
Free Cash Flow Margin	-1289.67%	-1507.92%	-1056.76%	-562.97%	97.24%	Upgrade
Free Cash Flow Per Share	-1.69	-2.67	-2.38	-1.76	0.83	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).